Carmignac Gestion increased its stake in Chemocentryx Inc (CCXI) by 26.83% based on its latest 2018Q3 regulatory filing with the SEC. Carmignac Gestion bought 275,273 shares as the company’s stock declined 9.75% with the market. The institutional investor held 1.30M shares of the health care company at the end of 2018Q3, valued at $16.45M, up from 1.03M at the end of the previous reported quarter. Carmignac Gestion who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $552.75M market cap company. The stock increased 4.29% or $0.45 during the last trading session, reaching $10.94. About 295,935 shares traded or 47.43% up from the average. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 69.59% since December 30, 2017 and is uptrending. It has outperformed by 69.59% the S&P500. Some Historical CCXI News: 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 ChemoCentryx 4Q EPS 80c
Exane Derivatives increased its stake in Petroleo Br.Adr (Put) (PBR) by 240% based on its latest 2018Q3 regulatory filing with the SEC. Exane Derivatives bought 12,000 shares as the company’s stock rose 24.82% while stock markets declined. The institutional investor held 17,000 shares of the oil & gas production company at the end of 2018Q3, valued at $952.00 million, up from 5,000 at the end of the previous reported quarter. Exane Derivatives who had been investing in Petroleo Br.Adr (Put) for a number of months, seems to be bullish on the $82.84B market cap company. The stock increased 2.00% or $0.26 during the last trading session, reaching $13.03. About 16.52M shares traded. PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) has risen 41.31% since December 30, 2017 and is uptrending. It has outperformed by 41.31% the S&P500. Some Historical PBR News: 29/05/2018 – BRAZIL’S TEMER SAYS PETROBRAS REFORMS WILL NOT BE UNDONE BY FUEL PRICE CONCESSIONS; 13/04/2018 – PETROBRAS SAYS FINANCING MATURES IN 2029, RESOURCES TO BE USED TO ACQUIRE GOODS AND SERVICES FROM UK SUPPLIERS – STATEMENT; 15/03/2018 – PETROBRAS SEES NET DEBT AT $77B AT END 2018; 23/05/2018 – Brazil truck strike forces Petrobras to slash diesel prices; 08/05/2018 – Petrobras Is Acting Like an Oil Major, It’s Working (Correct); 19/04/2018 – Macquarie, Mubadala, Engie bid for Brazil gas pipeline network owned by Petrobras; 25/04/2018 – CNBC Wires: Petrobras scraps Liquigas IPO, eyes antitrust risk in sale; 14/03/2018 – PETROBRAS SAYS IT’S ASSESSING ALTERNATIVES TO SELL LIQUIGAS; 28/03/2018 – BRAZIL’S STATE-RUN OIL COMPANY PETROBRAS SAYS COMPLETED HEDGE TO PROTECT PRICE FOR 128 MILLION BARRELS OF OIL PRODUCTION IN 2018; 13/03/2018 – BW OFFSHORE LTD BWO.OL – BW OFFSHORE HAS RECEIVED NOTICE FROM PETROBRAS OF EXERCISE OF A ONE-YEAR EXTENSION OF CONTRACTS RELATING TO FPSO CIDADE DE SÃO MATEUS
Investors sentiment decreased to 0.98 in Q3 2018. Its down 0.61, from 1.59 in 2018Q2. It turned negative, as 14 investors sold CCXI shares while 29 reduced holdings. 13 funds opened positions while 29 raised stakes. 26.80 million shares or 1.64% more from 26.37 million shares in 2018Q2 were reported. Landscape Cap Management Ltd Co holds 0.01% or 10,285 shares. Renaissance Ltd Liability Corporation holds 0.01% or 772,281 shares in its portfolio. Dimensional Fund Advisors Lp holds 0% or 547,771 shares in its portfolio. American Int Grp Inc has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 14,904 shares. Tower Llc (Trc) owns 626 shares for 0% of their portfolio. Strs Ohio holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 52,400 shares. California Public Employees Retirement Systems holds 67,452 shares or 0% of its portfolio. D E Shaw And stated it has 259,837 shares. Pnc Finance Services Grp Inc accumulated 74 shares. Moreover, Northern has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 300,109 shares. Moreover, Meeder Asset Mngmt has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). State Street holds 0% or 494,984 shares in its portfolio. Barclays Public Limited Liability Co has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). 17,811 are held by Sectoral Asset Management. Dorsey Wright reported 975 shares.
Carmignac Gestion, which manages about $11.80 billion US Long portfolio, decreased its stake in Stryker Corp (NYSE:SYK) by 638,480 shares to 959,076 shares, valued at $170.41M in 2018Q3, according to the filing. It also reduced its holding in Graftech International Ltd by 35,976 shares in the quarter, leaving it with 964,024 shares, and cut its stake in Nutrien Ltd.
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress – GlobeNewswire” on May 23, 2018, also Globenewswire.com with their article: “ChemoCentryx to Present at Two Upcoming Investor Conferences – GlobeNewswire” published on May 30, 2018, Globenewswire.com published: “New Research Coverage Highlights Ralph Lauren, CECO Environmental, PRA Group, ChemoCentryx, SunCoke Energy Partners, and Delek US â€” Consolidated Revenues, Company Growth, and Expectations for 2018 – GlobeNewswire” on November 27, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx, Inc. (CCXI) CEO Dr. Thomas Schall on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” published on August 09, 2018 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx terminates previously announced common stock offering – Seeking Alpha” with publication date: September 28, 2018.
Since October 16, 2018, it had 0 insider purchases, and 3 insider sales for $86.26 million activity. Another trade for 7,211 shares valued at $86,554 was made by Schall Thomas J. on Wednesday, November 7. GLAXOSMITHKLINE PLC sold $85.85 million worth of stock or 7.34M shares.
Among 8 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. ChemoCentryx had 12 analyst reports since September 3, 2015 according to SRatingsIntel. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) earned “Sell” rating by Zacks on Monday, September 21. The rating was maintained by Canaccord Genuity with “Buy” on Monday, November 12. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) has “Sell” rating given on Thursday, September 3 by Zacks. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) earned “Mkt Outperform” rating by JMP Securities on Tuesday, February 21. The company was downgraded on Tuesday, August 14 by JP Morgan. The company was maintained on Tuesday, March 13 by JP Morgan. The firm has “Buy” rating given on Thursday, August 10 by JMP Securities. The rating was maintained by Cowen & Co with “Hold” on Tuesday, August 8.
More notable recent PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) news were published by: Benzinga.com which released: “Wall Street Warming Up To Petrobras (NYSE:PBR) – Benzinga” on October 08, 2018, also Seekingalpha.com with their article: “Petrobras Sinks 45% In A Month… Time To Buy? – Seeking Alpha” published on June 25, 2018, Seekingalpha.com published: “New CEO seen curbing political interference, analysts say – Seeking Alpha” on November 19, 2018. More interesting news about PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) were released by: Seekingalpha.com and their article: “Brazil’s Most Valuable Company: Petrobras Is Back – Seeking Alpha” published on October 10, 2018 as well as Investorplace.com‘s news article titled: “15 Stocks Facing Big Political Risk in 2019 – Investorplace.com” with publication date: December 18, 2018.
Among 16 analysts covering Petroleo Brasileiro Petrobras SA (NYSE:PBR), 3 have Buy rating, 4 Sell and 9 Hold. Therefore 19% are positive. Petroleo Brasileiro Petrobras SA had 49 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was initiated by Credit Suisse with “Underperform” on Tuesday, January 12. Credit Suisse maintained PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) rating on Friday, May 26. Credit Suisse has “Buy” rating and $12.4000 target. The stock of PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) earned “Hold” rating by UBS on Friday, June 8. Credit Suisse maintained it with “” rating and $11 target in Thursday, March 23 report. On Thursday, May 24 the stock rating was downgraded by Bank of America to “Hold”. JP Morgan upgraded the shares of PBR in report on Tuesday, May 24 to “Neutral” rating. The stock of PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) earned “Neutral” rating by Credit Suisse on Friday, August 26. The rating was upgraded by Bank of America to “Buy” on Thursday, May 10. The stock of PetrÃ³leo Brasileiro S.A. – Petrobras (NYSE:PBR) earned “Underperform” rating by JP Morgan on Thursday, February 4. The rating was upgraded by Morgan Stanley to “Equal-Weight” on Tuesday, March 22.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.